Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Ambroxol on Secretion, Production and Gene Expression of Mucin from Cultured Airway Epithelial Cells

  • Lee, Hyun-Jae (Department of Pharmacology, School of Medicine, Chungnam National University) ;
  • Lee, Su-Yel (Department of Pharmacology, School of Medicine, Chungnam National University) ;
  • Cho, Kyoung-Rai (Department of Otorhinolaryngology, Sanggye Paik Hospital, College of Medicine, Inje University) ;
  • Jeon, Byeong-Kyou (Department of Radiologic Technology, Daegu Health College) ;
  • Lee, Jae-Woo (LG Life Science) ;
  • Bae, Heung-Seog (Department of Pharmacology, School of Medicine, Chungnam National University) ;
  • Lee, Choong-Jae (Department of Pharmacology, School of Medicine, Chungnam National University)
  • Received : 2010.07.29
  • Accepted : 2010.09.15
  • Published : 2011.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

In this study, we investigated whether ambroxol significantly affects secretion, production and gene expression of mucin from cultured airway epithelial cells. Confluent primary rat tracheal surface epithelial (RTSE) cells were pretreated with adenosine triphosphate (ATP) for 5 min and then treated for 30 min with ambroxol to assess the effect on mucin secretion using ELISA. Additionally, confluent NCI-H292 cells were pretreated with ambroxol for 30 min and then stimulated with EGF or PMA for 24 h. The MUC5AC mucin gene expression and mucin protein production were measured by RT-PCR and ELISA. The results were as follows: (1) ambroxol did not significantly affect ATP-induced mucin secretion from cultured RTSE cells; (2) ambroxol inhibited the production of MUC5AC mucin protein induced by EGF and PMA in NCI-H292 cells; (3) ambroxol also inhibited the expression of MUC5AC mucin gene induced by EGF and PMA in NCI-H292 cells. This result suggests that ambroxol can inhibit the production and gene expression of MUC5AC mucin, by directly acting on human airway epithelial cells.

Keywords

References

  1. Aliperta, A., Bellissimo, U., Turco, D. and Antinolfi, G. (1986) Normalization of bronchial exocrine pathology after endobronchial treatment with ambroxol. Int. J. Tissue React. 8, 167-174.
  2. Beeh, K. M., Beier, J., Esperester, A. and Paul, L. D. (2008) Anti-inflammatory properties of ambroxol. Eur. J. Med. Res. 13, 557-562.
  3. Gordon, J. L. (1986) Extracellular ATP: effects, sources and fate. Biochem.J. 233, 309-319.
  4. Heo, H. J., Lee, H. J., Yoon, C. S., Lim, S. P., Seok, J. H., Seo, U. K.and Lee, C. J. (2005) Effects of ambroxol, S-carboxymethylcysteine,dextromethorphan and noscapine on mucin release from airwaygoblet cells. Korean J. Physiol. Pharmacol. 9, 323-326.
  5. Hewson, C. A., Edbrooke, M. R. and Johnston, S. L. (2004) PMA inducesthe MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J. Mol. Biol. 344, 683-695. https://doi.org/10.1016/j.jmb.2004.09.059
  6. Kim, K. C., McCracken, K., Lee, B. C., Shin, C. Y., Jo, M. J., Lee, C.J. and Ko, K. H. (1997) Airway goblet cell mucin: its structure andregulation of secretion. Eur. Respir. J. 11, 2644-2649.
  7. Ko, K. H., Lee, C. J., Shin, C. Y., Jo, M. J. and Kim, K. C. (1999) Inhibitionof mucin release from airway goblet cells by polycationicpeptides. Am. J. Physiol. 277, L811-L815.
  8. Lazarowski, E. R. and Boucher, R. C. (2009) Purinergic receptors inairway epithelia. Curr. Opin. Pharmacol. 9, 262-267. https://doi.org/10.1016/j.coph.2009.02.004
  9. Lee, C. J., Paik, S. H., Ko, K. H. and Kim, K. C. (2002) Effects ofpolycationic peptides on mucin release from airway goblet cells:relationship between polymer size and activity. Inflamm. Res. 51,490-494. https://doi.org/10.1007/PL00012417
  10. Li, J. D., Dohrman, A. F., Gallup, M., Miyata, S., Gum, J. R., Kim, Y. S.,Nadel, J. A., Prince, A. and Basbaum, C. B. (1997) Transcriptionalactivation of mucin by Pseudomonas aeruginosa lipopolysaccharidein the pathogenesis of cystic fibrosis lung disease. Proc. Natl.Acad. Sci. USA. 94, 967-972. https://doi.org/10.1073/pnas.94.3.967
  11. Miyata, T., Kai, H., Saito, M., Okano, Y., Takahama, K., Nakagawa, M.and Kojima, S. (1986) Effects of ambroxol on pulmonary surfactant-analysis of the fatty acid composition of phosphatidylcholinein the sputum and normal respiratory tract fluid in rabbits. NipponYakurigaku Zasshi 88, 57-64. https://doi.org/10.1254/fpj.88.57
  12. Mutschler, E. and Derendorf, H. (1995) Drug actions, pp. 410-411,CRC Press, Boca Raton, Florida.
  13. Park, S. J., Kang, S. Y., Kim, N. S. and Kim, H. M. (2002) Phosphatidylinositol3-kinase regulates PMA-induced differentiation andsuperoxide production in HL-60cells. Immunopharmacol. Immunotoxicol.24, 211-226. https://doi.org/10.1081/IPH-120003751
  14. Rogers, D. F. and Barnes, P. J. (2006) Treatment of airway mucushypersecretion. Ann. Med. 38, 116-125. https://doi.org/10.1080/07853890600585795
  15. Shao, M. X., Ueki, I. F. and Nadel, J. A. (2003) TNF-alpha convertingenzyme mediated MUC5AC mucin expression in cultured humanairway epithelial cells. Proc. Natl. Acad. Sci. USA. 100, 11618-11623. https://doi.org/10.1073/pnas.1534804100
  16. Stetinova, V., Herout, V. and Kvetina, J. (2004) In vitro and in vivo antioxidantactivity of ambroxol. Clin. Exp. Med. 4, 152-158. https://doi.org/10.1007/s10238-004-0050-3
  17. Takeyama, K., Dabbagh, K., Shim, J. J., Dao-Pick, T., Ueki, I. F. andNadel, J. A. (2000) Oxidative stress causes mucin synthesis viatransactivation of epidermal growth factor receptor: role of neutrophils.J. Immunol. 164, 1546-1552. https://doi.org/10.4049/jimmunol.164.3.1546
  18. Takeyama, K., Dabbagh, K., Lee, H., Agusti, C., Lausier, J. A., Ueki, I.F., Grattan, K. M. and Nadel, J. A. (1999) Epidermal growth factorsystem regulates mucin production in airways. Proc. Natl. Acad.Sci. USA. 96, 3081-3086. https://doi.org/10.1073/pnas.96.6.3081
  19. Voynow, J. A. and Rubin, B. K. (2009) Mucins, mucus, and sputum.Chest 135, 505-512. https://doi.org/10.1378/chest.08-0412
  20. Wasano, K., Kim, K. C., Niles, R. M. and Brody, J.S. (1988) Membranedifferentiation markers of airway epithelial secretory cells. J. Histochem.Cytochem. 36, 167-178. https://doi.org/10.1177/36.2.3335774
  21. Yuan-Chen Wu, D., Wu, R., Reddy, S. P., Lee, Y. C. and Chang, M.M. (2007) Distinctive epidermal growth factor receptor/extracellularregulated kinase-independent and -dependent signaling pathwaysin the induction of airway mucin 5B and mucin 5AC expression byphorbol 12-myristate 13-acetate. Am. J. Pathol. 170, 20-32. https://doi.org/10.2353/ajpath.2007.060452

Cited by

  1. Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells vol.21, pp.4, 2013, https://doi.org/10.4062/biomolther.2013.051